AzTrials
AzTrials

Congenital Diaphragmatic HerniaINSPIRE-CDHNCT03094039

Initiation of Resuscitation While Attached to the Cord With Congenital Diaphragmatic Hernia

A study testing Ventilatory support while attached to the cord and Immediate cord clamping in people with Congenital Diaphragmatic Hernia, run by University of Alberta at 1 site in Canada.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study aims to measure the cardio-respiratory physiological consequences of initiating resuscitation during placental transfusion (PT) with an intact umbilical cord in infants with congenital diaphragmatic hernia (CDH). Read more about this study

Who is it for?
Ages Up to 10 minutes
Conditions the study is for
Congenital Diaphragmatic Hernia
What is being tested?
Ventilatory support while attached to the cord and Immediate cord clamping
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteCanada
Study dates
27 Apr 2017to 31 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 10 minutes
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Newborn infants with an antenatal diagnosed CDH.

Who cannot join

  • Severe antepartum or postpartum hemorrhage.
  • Any obstetrical concern.
  • Lack of parental consent.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Royal Alexandra Hospital

    Edmonton, Alberta, T5H 3V9

Other trials in Canada

About this study

Official title: Initiation of Resuscitative Care While on Placental Circulation for Infants With Congenital Diaphragmatic Hernia - a Randomized Pilot Trial

This study aims to measure the cardio-respiratory physiological consequences of initiating resuscitation during placental transfusion (PT) with an intact umbilical cord in infants with congenital diaphragmatic hernia (CDH). PT, mainly via delayed cord clamping, has been shown to offer a higher circulating blood volume, less need for blood transfusion, less need for inotropes in infants.

Currently infants with CDH receive immediate cord clamping (ICC) to facilitate immediate resuscitation including immediate intubation and mechanical ventilation.

With the development of a resuscitation platform (iNSPiRE), resuscitative care can now be commenced from birth in infants with CDH to benefit from PT.

Being tested
Ventilatory support while attached to the cord, Immediate cord clamping
Medical subject headings
Hernias, Diaphragmatic, Congenital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ventilatory support while attached to the cordProcedure or surgery

    Infants will receive active resuscitative care (intubation and ventilation) using a specific designed platform for 120 seconds during delayed cord clamping. Then the cord will be clamped forgoing resuscitation care.

  • Immediate cord clampingProcedure or surgery

    Infants will receive immediate cord clamping, transferred to the resuscitation table, intubated and mechanical ventilated according to our current Congenital Diaphragm Hernia protocol.

Study groups in NCT03094039
Study groupRoleWhat they receive
Ventilatory support while attached to the cordExperimentalInfants will receive active resuscitative care (intubation and ventilation) using a specific designed platform for 120 seconds during delayed cord clamping. Then the cord will be clamped forgoing resuscitation care.
Receives: Procedure: Ventilatory support while attached to the cord
Immediate cord clampingActive comparatorInfants will receive immediate cord clamping, transferred to the resuscitation table, intubated and mechanical ventilated according to our current Congenital Diaphragm Hernia protocol.
Receives: Procedure: Immediate cord clamping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of infants with hypotension requiring inotropes

    Proportion of infants with hypotension requiring inotropes in the first 24 hours after birth in the neonatal intensive care unit.

    Measured: first 24 hours after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2017
  2. Study start27 Apr 2017
  3. Primary completion31 Aug 2019 (estimated)
  4. Study completion31 Aug 2019 (estimated)

Why it stopped: no patient available for 18 months

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03094039
Sponsor's protocol ID
Pro00069729
Acronym
INSPIRE-CDH
Status last verified
Oct 2019
First submitted
17 Mar 2017
Last updated
3 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ventilatory support while attached to the cord and Immediate cord clamping in people with Congenital Diaphragmatic Hernia, run by University of Alberta at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 3 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of infants with hypotension requiring inotropes (time frame: first 24 hours after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2019; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in